ArticleOne health (Amsterdam, Netherlands)2025
Environmental transmission from bamboo rats: Mapping current and future talaromycosis risk in China under climate change.
Article in One health (Amsterdam, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Unraveling the increasing burden of allergies: Spatiotemporal dynamics of pollen allergy risk in China.Eco-Environment & Health · 2026Article
- Epidemiology and factors associated with Talaromyces marneffei detection in the mainland of China, 2022-2024: a cross-sectional study of hospitalized patients.BMC public health · 2026Article
- Risk prediction of echinococcosis in China under climate change: a One Health approach.Parasites & vectors · 2026Article
- Spatiotemporal dynamics of the capture rate of Rattus tanezumi and its implications for rodent-borne diseases in the Three Gorges Reservoir Area, China.Environmental monitoring and assessment · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Talaromycosis (TSM), a severe fungal infection caused by Methods: Here, we first employed a One Health framework to model current and future TM/TSM risk distributions across China. Using the Maximum Entropy (Maxent) model, we predicted the habitat suitability for three key bamboo rat reservoir species. Based on this, we developed the risk distribution maps of TM/TSM across China by integrating socio-economic factors. Results: Accurate modeling results (AUC: 0.958-0.999) identified precipitation- and temperature- related factors as decisive environmental drivers. Specifically, high-suitability regions were concentrated in Southern/Southwestern China (Yunnan, Guangxi, Guizhou, Sichuan, Hunan, and Guangdong Provinces), coincident with known endemic areas. Furthermore, human infection risk maps were generated by integrating suitability distribution with socio-economic factors (HIV incidence, population density, GDP). High-risk hotspots stratified by HIV status confirmed core endemic zones for HIV-positive populations and identified broader risk areas for HIV-negative populations (e.g., parts of Guangdong, Jiangxi and Fujian Provinces). Projections under different climate change scenarios showed host suitability will decrease under low emissions (SSP126) but expand under high emissions (SSP585), indicating dynamic future TM/TSM risk patterns and disease administration dependent on emission conditions. Conclusions: Collectively, these findings first revealed high-resolution predictive risk maps of TM/TSM in China and provided valuable reference for targeted public health interventions. The proposed methods in this study will also shed light on the prevention and administration of other "fungi - animal host - human" diseases in both current and emerging risk zones under climate change in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.